IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0315509.html
   My bibliography  Save this article

Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands

Author

Listed:
  • Bart Slob
  • Tanja Fens
  • Maaike Weersma
  • Maarten Postma
  • Cornelis Boersma
  • Lisa de Jong

Abstract

Aim: The recent EMPA-KIDNEY trial showed evidence for preventing disease progression in adult patients with chronic kidney disease (CKD) treated with empagliflozin. It is however yet unknown if use of empagliflozin is cost effective in the Netherlands. We aimed to evaluate the cost effectiveness of empagliflozin in adult patients with CKD in the Netherlands. Methods: A cost-effectiveness analysis was conducted using a Markov state microsimulation model, simulating kidney progression of CKD patients with eGFR

Suggested Citation

  • Bart Slob & Tanja Fens & Maaike Weersma & Maarten Postma & Cornelis Boersma & Lisa de Jong, 2024. "Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands," PLOS ONE, Public Library of Science, vol. 19(12), pages 1-16, December.
    • Handle: RePEc:plo:pone00:0315509
    DOI: 10.1371/journal.pone.0315509
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0315509
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0315509&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0315509?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0315509. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.